Opportunity Information: Apply for RFA OD 23 015
This NIH funding opportunity (RFA-OD-23-015) is a targeted Request for Applications for revision applications to currently active NIH R01 awards. It sits within the ADVANCE (Advancing Prevention Research for Health Equity) program and is led by the NIH Office of Disease Prevention (ODP) under the Office of the Director, Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). The main purpose is to add new, time-sensitive work onto an existing R01 by supporting additional studies that develop and evaluate interventions aimed specifically at preventing menthol cigarette use and helping people stop using menthol cigarettes, with a clear emphasis on populations that experience health disparities. Clinical trials are allowed but not required, meaning applicants can propose either clinical-trial or non-clinical-trial research as long as it fits the intervention development and/or evaluation focus.
A key feature of this opportunity is that it is not for brand-new standalone R01 projects; it is for revisions (formerly referred to as competitive revisions) to active R01 grants. In practice, that means the applicant needs to already hold an NIH-funded R01 that is currently active, and the proposed menthol-focused aims should logically extend, enhance, or accelerate the parent award rather than replace it. The revision mechanism is intended to enable research teams to build onto existing infrastructure, cohorts, partnerships, data systems, or intervention platforms to answer important questions about menthol smoking prevention and cessation in a faster and more efficient way than starting from scratch.
The public health target is menthol cigarettes, which have been widely associated with increased initiation and greater difficulty quitting for many smokers, and have been disproportionately marketed and used in several communities experiencing inequities. Consistent with the ADVANCE health equity framing, the solicitation centers on interventions for populations that experience health disparities, which can include communities defined by race and ethnicity, socioeconomic position, geography, disability status, sexual and gender minority status, or other factors linked to unequal health burdens. The research supported is intended to be intervention-focused (developing, adapting, testing, or evaluating prevention and cessation approaches), rather than purely descriptive surveillance work.
Eligibility is broad across many U.S.-based organization types that commonly apply for NIH grants. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations that are not federally recognized; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other organizations. The announcement also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it draws clear boundaries around foreign involvement: non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed under this RFA.
From an administrative standpoint, the opportunity is categorized as a discretionary grant under the health and education activity space and is associated with multiple CFDA numbers (93.121, 93.233, 93.279, 93.307, 93.313, 93.393, 93.837, 93.838, 93.839, 93.840), reflecting the NIH’s multi-institute structure and the way prevention and tobacco-related research can span several NIH program areas. The posted award ceiling is $200,000 (generally interpreted as the maximum additional amount that can be requested for the revision, subject to NIH budget rules and the parent award context). The original closing date listed for the RFA was June 19, 2023, and the opportunity was created on March 30, 2023. No expected number of awards is specified in the provided data, which typically means the final number depends on application volume, quality, and available funds.
Overall, the RFA is designed to quickly expand the evidence base for menthol cigarette prevention and cessation strategies by leveraging ongoing R01 projects and directing added resources toward intervention research that can reduce tobacco-related inequities. Applicants are expected to propose well-justified additional aims that fit the parent R01, focus on populations experiencing health disparities, and generate practical, testable knowledge about what helps prevent menthol cigarette use and what improves quitting outcomes in real-world settings.Apply for RFA OD 23 015
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.233, 93.279, 93.307, 93.313, 93.393, 93.837, 93.838, 93.839, 93.840.
- This funding opportunity was created on 2023-03-30.
- Applicants must submit their applications by 2023-06-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
Previous opportunity: BJA FY 23 Justice and Mental Health Collaboration Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 23 015
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 23 015) also looked into and applied for these:
| Funding Opportunity |
|---|
| Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional) Apply for RFA CA 23 023 Funding Number: RFA CA 23 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) Apply for RFA CA 23 033 Funding Number: RFA CA 23 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 001 Funding Number: RFA DE 24 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) Apply for PAR 23 158 Funding Number: PAR 23 158 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 23 157 Funding Number: PAR 23 157 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 155 Funding Number: PAR 23 155 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 020 Funding Number: RFA DA 24 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 038 Funding Number: RFA DA 24 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 021 Funding Number: RFA DA 24 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 23 170 Funding Number: PAR 23 170 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) Apply for RFA DA 24 022 Funding Number: RFA DA 24 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) Apply for RFA DA 24 015 Funding Number: RFA DA 24 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) Apply for RFA DA 24 023 Funding Number: RFA DA 24 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029 Funding Number: RFA CA 23 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 24 005 Funding Number: RFA CA 24 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 23 034 Funding Number: RFA CA 23 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035 Funding Number: RFA CA 23 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) Apply for RFA CA 23 038 Funding Number: RFA CA 23 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) Apply for RFA DA 24 019 Funding Number: RFA DA 24 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) Apply for RFA DA 24 016 Funding Number: RFA DA 24 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 23 015", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.